Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice

Fitoterapia

Volumn 83, Issue 8, 2012, Pages 1687-1692

  Udomsuk, Latiporn ^a,b   Chatuphonprasert, Waranya ^a,c   Monthakantirat, Orawan ^a   Churikhit, Yaowared ^a   Jarukamjorn, Kanokwan ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UBON RATCHATHANI UNIVERSITY   (Thailand)

^c MAHASARAKHAM UNIVERSITY   (Thailand)

Author keywords

Estradiol; Miroestrol; OPG; Osteoporosis; Pueraria candollei var. mirifica; RANKL

Indexed keywords

ESTRADIOL BENZOATE; MESSENGER RNA; MIROESTROL; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHYTOESTROGEN; PUERARIA EXTRACT; PUERARIA MIRIFICA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE REPRESSION; HORMONE SUBSTITUTION; LIVER; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERARIA; PUERARIA MIRIFICA;

MUS; PUERARIA;

EID: 84870808544     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2012.09.024     Document Type: Article

References (26)

1. E.S. Christenson, X. Jiang, R. Kagan, and P. Schnatz Osteoporosis management in post-menopausal woman Minerva Ginecol 64 2012 181 194
2. E. Jiang, Z. Wang, Q. Meng, S. Li, F. Wang, G. Shao, and L. Zhang Study on bone density at various skeletal site for the diagnosis of primary osteoporosis Cell Biochem Biophys 64 2012 1 3
3. M.G. Glazeir, and M.A. Bowmwn A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy Arch Intern Med 161 2001 1161 1172
4. S. Davison, and S.R. Davis Hormone replacement therapy: current controversies Clin Endocrinol 58 2003 249 261
5. H.D. Nelson Assessing benefits and harms of hormone replacement therapy: clinical applications JAMA 288 2002 882 884
6. C.B. Tempfer, E.K. Bentz, S. Leodolter, G. Tscherne, F. Reuss, and H.S. Cross Phytoestrogen in clinical practice: a review of the literature Fertil Steril 87 2007 1243 1249
7. L. Udomsuk, K. Jarukamjorn, H. Tanaka, and W. Putalun Production of isoflavonoids in callus cultures of Pueraria candollei var. mirifica Z Naturforsch 64 2009 239 243
8. N. Urasopon, Y. Hamada, K. Asaoka, W. Cherdshewasart, and S. Malaivijitnond Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats Maturitas 56 2007 322 331
9. N. Urasopon, Y. Hamada, W. Cherdshewasart, and S. Malaivijitnond Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats Maturitas 59 2008 137 148
10. W. Tayasatkulkovit, N. Charoenphandhu, K. Wongdee, J. Thongbunchoo, N. Krishnamra, and S. Malaivijitnond Upregulated of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica Phytomedicine 19 2012 1147 1155
11. I. Pande Osteoporosis in men Best Pract Res Clin Rheumatol 15 2001 415 427
12. L. Udomsuk, T. Juengwatanatrakul, W. Putalun, and K. Jarukamjorn Bimodal action of miroestrol and deoxymiroestrol, phytoestrogens from Pueraria candollei var. mirifica, on hepatic CYP2B9 and CYP1A2 expressions and antilipid peroxidation in mice Nutr Res 32 2012 45 51
13. G.K. Benson, A.T. Cowie, and Z.D. Hosking Mammogenic activity of miroestrol Endocrinology 21 1961 354 360
14. H.E.H. Jones, H.P. Waynforth, and G.S. Pope The effect of miroestrol on vaginal cornification, pituitary function and pregnancy in the rat J Endocrinol 22 1961 293 302
15. D.L. Lacey, E. Timms, H.L. Tan, M.J. Kelly, C.R. Dunstan, and T. Burgess Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176
16. T. Krakauer Nuclear factor-kappa B: fine-tuning a central integrator of diverse biologic stimuli Int Rev Immunol 27 2008 286 292
17. T.C. Spelsberg, M. Subramaniam, B.L. Riggs, and S. Khosla The actions and interactions of sex steroids and growth factors/cytokines on the skeleton Mol Endocrinol 13 1999 75 81
18. K. Jarukamjorn, T. Sakuma, J. Miyaura, and N. Nemoto Different regulation of the expression of mouse hepatic cytochrome P450 CYP2B enzyme by glucocorticoid and phenobarbital Arch Biochem Biophys 396 1999 89 99
19. H. Sigglekow, T. Eidnerr, G. Lehmann, V. Viereck, U. Raddatz, and U. Munzel Bone Miner Res 3 2003 529 538
20. M.J. Henry, J.A. Pasco, and G.C. Nicholson Prevalence of osteoporosis in Australian women Geelong osteoporosis study J Clin Densitom 3 2000 261 268
21. S.C. Manolagas Birth and death of bone cells: basic regulatory mechanism and implications for the pathogenesis and treatment of osteoporosis Endocr Rev 21 2000 115 137
22. R.B. Kimble, S. Brain, and R. Pacifici The function block of TNF but not of IL-6 prevents bone loss in ovariectomiczed mice Bone Miner Res 12 1997 935 941
23. Y. Zhang, Q. Li, H.-Y. Wan, W.G. Helferich, and M.-S. Wong Genistein and soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice J Nutr 139 2009 2230 2236
24. B. Ettinger Prevention of osteoporosis: treatment of estradiol deficiency Obstet Gynecol 72 1988 125 175
25. Y.U. Bae, and M.H. Kim Calcium and magnesium supplementation improves serum OPG/RANKL in calcium-deficient ovariectomized rats Calcif Tissue Int 87 2010 365 372
26. Q.P. Wang, L. Yang, X.P. Li, H. Xie, E.Y. Liao, I. Wang, and X.H. Lao Effect of 17β-estradiol on adiponectin regulation of osteoprotegenin and receptor activator of nuclear factor-Ò¡B ligand Bone 51 2012 515 523